Constructing and Validating 3D-pharmacophore Models to a Set of MMP-9 Inhibitors for Designing Novel Anti-melanoma Agents

Turra KM; Rivelli DP; Barros SBD; de Souza, Ana Olívia.
Mol. Inf ; 35(6-7): p. 238-252, 2016.
Artículo | SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib13653

Documentos relacionados

  1. Volodymyr Oleksiyovych SHLYAKHOVENKO.
  2. Watson, autonomy and value flexibility: revisiting the debate.
  3. Academic Promotion and Oncology Drug Development: Role, Responsibilities, and Integrity
  4. Common Sense Oncology: outcomes that matter.
  5. Annals of Oncology 2018-2023.
  6. Common Sense Oncology: including everyone.
  7. Common Sense Oncology: including everyone.
  8. Common Sense Oncology: including everyone - Authors' reply.
  9. ESMO Guidance for Reporting Oncology real-World evidence (GROW).
  10. Risk Model Development and Validation in Clinical Oncology: Lessons Learned.